お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
980200

破傷風:世界の臨床試験レビュー(2020年下半期)

Tetanus Disease - Global Clinical Trials Review, H2, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 276 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.78円
破傷風:世界の臨床試験レビュー(2020年下半期)
出版日: 2020年12月30日
発行: GlobalData
ページ情報: 英文 276 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、破傷風について調査しており、世界主要国において実施された試験数とその平均登録数の概要、地域・フェーズ・臨床試験ステータス・エンドポイントステータス・スポンサータイプ別の臨床試験、臨床試験が進行中の薬剤、過去5年間の登録動向などのデータを掲載しています。

目次

目次

表のリスト

図のリスト

  • レポートガイダンス
  • 臨床試験調査範囲
  • 地域別の臨床試験
  • 国別の臨床試験と平均登録
  • アジア太平洋において臨床試験に貢献している主要5か国
  • 欧州において臨床試験に貢献している主要5か国
  • 北米において臨床試験に貢献している主要国
  • 中東とアフリカにおいて臨床試験に貢献している主要5か国
  • 中南米において臨床試験に貢献している主要5か国
  • G7諸国別:感染症臨床試験における破傷風の割合
  • フェーズ別:G7諸国における臨床試験
  • 臨床試験ステータス別:G7諸国における臨床試験
  • E7諸国別:感染症臨床試験における破傷風の割合
  • フェーズ別:E7諸国における臨床試験
  • 臨床試験ステータス別:E7諸国における臨床試験
  • フェーズ別の臨床試験
  • フェーズ別の進行中の臨床試験
  • 臨床試験ステータス別の臨床試験
  • エンドポイントステータス別の臨床試験
  • 一定期間にわたって募集された被験者
  • スポンサータイプ別の臨床試験
  • 主要スポンサー
  • 治療薬の臨床試験に参加している主要企業
  • 主要薬剤
  • 臨床試験プロファイルのスナップショット

付録

  • 略語
  • 定義
  • 調査手法
  • 2次調査
  • GlobalDataについて
  • お問い合わせ
  • 情報源
図表

List of Tables

List of Tables

  • Tetanus Therapeutics, Global, Clinical Trials by Region, 2020*
  • Tetanus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Tetanus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Tetanus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Tetanus Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Tetanus Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Tetanus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Tetanus Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Tetanus to Infectious Disease Clinical Trials, G7 Countries (%), 2020*
  • Tetanus Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Tetanus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Tetanus to Infectious Disease Clinical Trials, E7 Countries (%), 2020*
  • Tetanus Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Tetanus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Tetanus Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Tetanus Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Tetanus Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Tetanus Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Tetanus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Tetanus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Tetanus Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Tetanus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Tetanus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Tetanus Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Tetanus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Tetanus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Tetanus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Tetanus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Tetanus Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Tetanus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
  • Tetanus Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Tetanus to Infectious Disease Clinical Trials, G7 Countries (%), 2020*
  • Tetanus Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Tetanus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Tetanus to Infectious Disease Clinical Trials, E7 Countries (%), 2020*
  • Tetanus Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Tetanus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Tetanus Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Tetanus Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Tetanus Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Tetanus Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Tetanus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Tetanus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Tetanus Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Tetanus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Tetanus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology
目次
Product Code: GDHC6585CTIDB

GlobalData's clinical trial report, "Tetanus Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Tetanus Clinical trials scenario. This report provides top line data relating to the clinical trials on Tetanus . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.*

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Tetanus to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Tetanus to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Tetanus Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.